Crossmark

Regulatory alignment in FDA expedited pathways for infectious diseases: a decadal review with predictive modeling insights

Crossref DOI link: https://doi.org/10.1038/s41598-025-30452-0

Published Online: 2025-12-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tam, Nguyen Thanh

Sayed, Ahmed M. https://orcid.org/0000-0003-0244-3457
Dadam, Mohammad Najm https://orcid.org/0000-0002-8814-0205
Elsheikh, Randa https://orcid.org/0000-0002-5811-9907
Aziz, Jeza Muhammad Abdul https://orcid.org/0000-0002-1522-1880
Gad, Abdelrahman Gamil https://orcid.org/0000-0002-4461-3517
Nguyen, Thi Thu Hoai https://orcid.org/0000-0003-4869-1827
Tran, Phillip https://orcid.org/0000-0003-3329-2276
Zhang, Zhilin https://orcid.org/0000-0002-2442-0478
Ohmagari, Norio https://orcid.org/0000-0002-4622-8970
Huy, Nguyen Tien https://orcid.org/0000-0002-9543-9440
License Information

Text and Data Mining valid from 2025-12-13

Version of Record valid from 2026-01-07
More Information

Article History

Received: 1 August 2025

Accepted: 25 November 2025

First Online: 13 December 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.